Yahoo Web Search

Search results

    • Q1 2024 Axsome Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 34 minutes ago

      In March, we announced that the Phase 3 simply trial of AXS-12 in narcolepsy achieved this primary endpoint and significantly reduced the frequency of cataplexy attacks as ...